Drug Information

Drug General Information
Drug ID
D04ERQ
Former ID
DIB003029
Drug Name
CXD-101
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524509]
Company
AstraZeneca plc
Target and Pathway
Target(s) Histone deacetylase Target Info Inhibitor [530566]
References
Ref 524509ClinicalTrials.gov (NCT01977638) Phase 1 Trial of CXD101 in Patients With Advanced Cancer. U.S. National Institutes of Health.
Ref 530566Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. Clin Microbiol Infect. 2010 Sep;16(9):1482-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.